Pipobroman
Top View
- Cancer-80.Xls ID MOLENAME BIOACTIVITY SOURCE 01502116 1,2
- Mutagenicity of Several Classes of Antitumor Agents to Salmonella Typhimurium TA98, TA100, and TA921
- MANUAL for Medical Facilities
- Inhibitors of the Menin-Mll Interaction Inhibitoren Der Menin-Mll-Interaktion Inhibiteurs De L’Interaction Ménine-Mll
- Acute Megakaryoblastic Transformation Of
- ©Ferrata Storti Foundation
- Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
- Blast Crisis
- SAFE HANDLING of HAZARDOUS DRUGS Updated 5/22/2020
- TOHTUNUTTUUUS009993467B2 (12 ) United States Patent ( 10 ) Patent No
- Pemetrexed Disodium/Pipobroman 763
- [2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
- Polycythemia Vera and Essential Thrombocythemia Lorenzo Falchi, MD, and Srdan Verstovsek, MD, Phd
- NIOSH Alert: Preventing Occupational Exposures to Antineoplastic
- Supplementary Table 1: List of Drugs and Their Binding Energies to ACE and ACE2
- An Open Access Database of Licensed Cancer Drugs Pan Pantziarka 1,2, §, Rica Capistrano 1, Arno De Potter 3, Liese Vandeborne 1, Gauthier Bouche 1
- WO 2017/035116 Al O
- Oncological Drug Poster